Defective clearance of adenovirus in IRF-1-/- mice associated with defects in NK and T cells but not macrophages

Scandinavian Journal of Immunology

Volumn 60, Issue 1, 2004, Pages 89-99

  Xu, X ^a,b   Zhang, H G ^a,c   Liu, Z Y ^a   Wu, Q ^a   Yang, P A ^a   Sun, S H ^a   Chen, J ^a   Hsu, H C ^a   Mountz, J D ^a,c,d  

^a University of Alabama at Birmingham   (United States)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD8 ANTIGEN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 18; RECOMBINANT BETA GALACTOSIDASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIVER CELL; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SIGNAL TRANSDUCTION; SPLEEN CELL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UPREGULATION; VIRUS RECOMBINANT; WILD TYPE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DNA-BINDING PROTEINS; FEMALE; GENETIC VECTORS; INTERFERON REGULATORY FACTOR-1; KILLER CELLS, NATURAL; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPLEEN;

EID: 3242686306     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01461.x     Document Type: Article

References (53)

1. Barr D, Tubb J, Ferguson D et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther 1995;2:151-5.
2. Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996;70:8934-43.
3. Boucher RC. Current status of CF gene therapy. Trends Genet 1996;12:81-4.
4. + CTLs in vivo. J Immunol 1995;155:2564-70.
5. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995;69:2004-15.
6. Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E. Circumventing the immune response to adenovirus-mediated gene therapy. Gene Ther 1996;3:154-62.
7. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40.
8. Yang Y, Su Q, Grewal IS, Schilz R, Flavell RA, Wilson JM. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol 1996;70:6370-7.
9. Zhang HG, Liu D, Heike Y et al. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells. Nat Biotechnol 1998;16:1045-9.
10. Schroder G, Risch K, Nizze H et al. Immune response after adenoviral gene transfer in syngeneic heart transplants: effects of anti-CD4 monoclonal antibody therapy. Transplantation 2000;70:191-8.
11. Peng Y, Falck-Pedersen E, Elkon KB. Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo. J Immunol 2000;165:1470-8.
12. Ye X, Robinson MB, Pabin C, Batshaw ML, Wilson JM. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse. Gene Ther 2000;7:1761-7.
13. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1995;1:890-3.
14. Elkon KB, Liu CC, Gall JG et al. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc Natl Acad Sci USA 1997;94:9814-9.
15. Lieber A, He CY, Meuse L et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 1997;71:8798-807.
16. Lieber A, He CY, Meuse L, Himeda C, Wilson C, Kay MA. Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver. J Virol 1998;72:9267-77.
17. Feigenblum D, Walker R, Schneider RJ. Adenovirus induction of an interferon-regulatory factor during entry into the late phase of infection. J Virol 1998;72:9257-66.
18. Reis LF, Ruffner H, Stark G, Aguet M, Weissmann C. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J 1994;13:4798-806.
19. Tanaka N, Taniguchi T. The interferon regulatory factors and oncogenesis. Semin Cancer Biol 2000;10:73-81.
20. Pine R. Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J Virol 1992;66:4470-8.
21. Harada H, Kitagawa M, Tanaka N et al. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993;259:971-4.
22. Zoeller B, Popp M, Walter A, Redmann-Muller I, Lodemann E, Jungwirth C. Overexpression of chicken interferon regulatory factor-1 (Ch-IRF-1) induces constitutive expression of MHC class I antigens but does not confer virus resistance to a permanent chicken fibroblast cell line. Gene 1998;222:269-78.
23. Matsuyama T, Kimura T, Kitagawa M et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993;75:83-97.
24. Ogasawara K, Hida S, Azimi N et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998;391:700-3.
25. + (NK1 + T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med 1998;187:967-72.
26. Routes JM. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells. J Immunol 1993;150:4315-22.
27. Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994;1:433-42.
28. Routes JM, Cook JL. E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells. Virology 1995;210:421-8.
29. Liu ZX, Govindarajan S, Okamoto S, Dennert G. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 2000;164:6480-6.
30. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001;19:623-55.
31. Haberberger TC, Kupfer K, Murphy JE. Profiling of genes which are differentially expressed in mouse liver in response to adenoviral vectors and delivered genes. Gene Ther 2000;7:903-9.
32. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995;3:207-20.
33. Zhang HG, Zhou T, Yang P, Awards CK III, Curiel DT, Mountz JD. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum Gene Ther 1998;9:1875-84.
34. Otake K, Ennist DL, Harrod K, Trapnell BC. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther 1998;9:2207-22.
35. Xing Z, Zganiacz A, Wang J, Divangahi M, Nawaz F. IL-12-independent Th1-type immune responses to respiratory viral infection: requirement of IL-18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive Th1-type lymphocytes. J Immunol 2000;164:2575-84.
36. Taki S, Sato T, Ogasawara K et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997;6:673-9.
37. Lohoff M, Ferrick D, Mittrucker HW et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997;6:681-9.
38. Hurgin V, Novick D, Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci USA 2002;99:16957-62.
39. Fantuzzi G, Reed D, Qi M, Scully S, Dinarello CA, Senaldi G. Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. Eur J Immunol 2001;31:369-75.
40. Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 1989;337:270-2.
41. Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ 1991;2:401-7.
42. Jani A, Menichella D, Jiang H et al. Modulation of cell-mediated immunity prolongs adenovirus-mediated transgene expression in sciatic nerve. Hum Gene Ther 1999;10:787-800.
43. Chow WA, Fang JJ, Yee JK. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J Immunol 2000;164:3512-8.
44. Kirchhoff S, Sebens T, Baumann S et al. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J Immunol 2002;168:1226-34.
45. Wolff G, Worgall S, van Rooijen N, Song WR, Harvey BG, Crystal RG. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol 1997;71:624-9.
46. Alemany R, Suzuki K, Curiel DT. Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 2000;81:2605-9.
47. Tao N, Gao GP, Parr M et al. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther 2001;3:28-35.
48. Schiedner G, Hertel S, Johnston M, Dries V, van Rooijen N, Kochanek S. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors. Mol Ther 2003;7:35-43.
49. Xu X, Sumita K, Feng C et al. Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice. J Immunol 2001;167:235-41.
50. Liu J, Cao S, Herman LM, Ma X. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatoty factor 1. J Exp Med 2003;198:1265-76.
51. Maruyama S, Sumita K, Shen H et al. Identification of IFN regulatory factor-1 binding site in IL-12 p40 gene promoter. J Immunol 2003;170:997-1001.
52. Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994;180:977-84.
53. Kamijo R, Harada H, Matsuyama T et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994;263:1612-5.